Insulinoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:
Pancreatic insulinoma histology 2.JPG|Histopathology of pancreatic endocrine tumor (insulinoma)<ref name=123> Neuroendocrine tumour of the pancreas. Libre Pathology. http://librepathology.org/wiki/index.php/Neuroendocrine_tumour_of_the_pancreas Accessed on September, 30 2015</ref>
Pancreatic insulinoma histology 2.JPG|Histopathology of pancreatic endocrine tumor (insulinoma)<ref name=123> Neuroendocrine tumour of the pancreas. Libre Pathology. http://librepathology.org/wiki/index.php/Neuroendocrine_tumour_of_the_pancreas Accessed on September, 30 2015</ref>


Pancreatic insulinoma histopathology 3.JPG|Histopathology of pancreatic endocrine tumor (insulinoma). Chromogranin A immunostain<ref name=123> Neuroendocrine tumour of the pancreas. Libre Pathology. http://librepathology.org/wiki/index.php/Neuroendocrine_tumour_of_the_pancreas Accessed on September, 30 2015</ref>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 17:31, 1 October 2015

Insulinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Insulinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Insulinoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Insulinoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Insulinoma pathophysiology

CDC on Insulinoma pathophysiology

Insulinoma pathophysiology in the news

Blogs on Insulinoma pathophysiology

Directions to Hospitals Treating Insulinoma

Risk calculators and risk factors for Insulinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Pathophysiology

  • Multiple endocrine neoplasia type 1 is an autosomal dominant disorder caused by alterations of the MEN1 gene located at chromosomal region 11q13.
  • Approximately 10% of insulinomas are multiple and 10% malignant.[2]



<gallery widths=200px> Pancreatic insulinoma Histology 1.JPG|Histopathology of pancreatic endocrine tumor (insulinoma). H&E stain

Pancreatic insulinoma histology 2.JPG|Histopathology of pancreatic endocrine tumor (insulinoma)

Pancreatic insulinoma histopathology 3.JPG|Histopathology of pancreatic endocrine tumor (insulinoma). Chromogranin A immunostain

References

  1. Murray PD, McKenzie DT, Swain SL, Kagnoff MF (1987). "Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression". J Immunol. 139 (8): 2669–74. PMID 3498768.
  2. Insulinoma. Dr Yuranga Weerakkody and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/insulinoma


Template:WikiDoc Sources